Advancing the Role of Pharmacy in Tobacco Cessation

虽然大多数烟草使用者想戒烟，但大多数人没有得到专业帮助， 超过5%的人尝试自己戒烟是成功的。戒烟最有效的方法是 虽然在药物治疗和咨询方面取得了进展，但很少有临床医生在实践中常规地解决烟草使用问题。近年来，只有 在增加接受专业治疗的患者比例方面取得了一些小的进展， 援助或使用FDA批准的戒烟药物，需要新的方法来打破现状。 一个很大程度上尚未开发但很容易获得的提供者群体是药剂师。2004年，新墨西哥州 实施了第一个授予药剂师处方戒烟药物权力的议定书， 最近又有8个国家将类似立法签署成为法律（另有14个国家正在这一过程中）。 虽然通过立法是重要的第一步，但第二步-使专业人员做好准备， 这些新的规范性权威-同样重要。 这项R25申请的主要目的是向试图推进 药房在戒烟中的作用。通过与主要组织的合作，我们将开发和 传播培训方案，为所有成员的药学专业：药剂师，药学技术人员， 和药剂师导师谁主机体验培训网站的药学学生。程序开发和 传播将以理论为基础，建立在我们团队先前工作中建立的强有力的方法论基础上。 更广泛地说，我们将在制药行业、州卫生部和烟草业之间建立桥梁 戒烟热线，从而为患者提供更多的循证戒烟方法。 R25应用的具体目标是： AIM 1.为（a）药房开发一套实时和持久的基于网络的戒烟培训计划 人员，包括药剂师和技术人员，以及（B）主持体验的药剂师导师 药学专业学生的培训场所。 AIM 2.在试点阶段I（01/02年），为印第安纳州药剂师开展一系列5个现场培训项目， 为印第安纳州的药剂师和技术人员开展网络培训。 AIM 3.在全面启动阶段之前，根据第一阶段参与者的反馈酌情修订材料 II（02-05年），在药剂师可以开吸烟处方的州提供现场和网络培训 停止药物。总体而言，估计将培训5 680名药剂师和1 000名技术员。 AIM 4.采用混合方法评估方法来估计培训计划的范围和影响。 这项拟议的教育倡议是及时和必要的-重要的是，它利用了提高 由于最近的立法进步，它建立在我们团队数十年的培训经验基础上 药剂师、技术人员和学生帮助他们的病人戒烟。

Although most tobacco users would like to quit, the majority do not receive professional assistance, and fewer than 5% who try to quit on their own are successful. The most effective approach for quitting combines pharmacotherapy with counseling, yet few clinicians routinely address tobacco use in practice. In recent years, only minor advancements have been made toward increasing the proportion of patients who receive professional assistance or use FDA-approved cessation medications, and novel approaches are needed to disrupt the status quo. One largely untapped yet highly accessible population of providers is pharmacists. In 2004, New Mexico implemented the first protocol granting pharmacists authority to prescribe smoking cessation medications, and eight additional states recently have signed similar legislation into law (with another 14 states in the process). While the passage of legislation is an essential first step, the second step – preparing the profession to act on these new prescriptive authorities – is equally important. The primary objective of this R25 application is to provide assistance to states attempting to advance pharmacy’s role in tobacco cessation. Through partnerships with key organizations, we will develop and disseminate training programs for all members of the pharmacy profession: pharmacists, pharmacy technicians, and pharmacist preceptors who host experiential training sites for pharmacy students. Program development and dissemination will be grounded in theory, building upon strong methodology established in our team’s prior work. More broadly, we will build bridges between the pharmacy profession, State Departments of Health, and tobacco quitlines, thereby providing patients with increased access to evidence-based methods for quitting. The specific aims of this R25 application are to: AIM 1. Develop a suite of live and enduring web-based tobacco cessation training programs for (a) pharmacy personnel, including pharmacists and technicians, and (b) pharmacist preceptors who host experiential training sites for pharmacy students. AIM 2. In a pilot Phase I (Years 01/02), conduct a series of 5 live training programs for Indiana pharmacists and launch web-based trainings for Indiana pharmacists and technicians. AIM 3. Revise materials, as appropriate, based on feedback from Phase I participants prior to a full-launch Phase II (Years 02–05), providing live and web-based trainings in states where pharmacists can prescribe smoking cessation medications. Overall, an estimated 5,680 pharmacists and 1,000 technicians will be trained. AIM 4. Apply a mixed methods evaluation approach to estimate the reach and impact of the training programs. This proposed educational initiative is both timely and needed—importantly, it capitalizes on heightened awareness due to recent legislative advances, and it builds upon our team’s decades of experience in training pharmacists, technicians, and students to assist their patients with the cessation of tobacco use.